相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Purification of human respiratory syncytial virus fusion glycoprotein
Yanpeng Zheng et al.
PROTEIN EXPRESSION AND PURIFICATION (2012)
Current progress on development of respiratory syncytial virus vaccine
Jun Chang
BMB REPORTS (2011)
A review of palivizumab and emerging therapies for respiratory syncytial virus
Kristin A. Shadman et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
Barney S. Graham
IMMUNOLOGICAL REVIEWS (2011)
Soluble Respiratory Syncytial Virus Fusion Protein in the Fully Cleaved, Pretriggered State Is Triggered by Exposure to Low-Molarity Buffer
Supranee Chaiwatpongsakorn et al.
JOURNAL OF VIROLOGY (2011)
RSV 2010: Recent advances in research on respiratory syncytial virus and other pneumoviruses
Grada M. van Bleek et al.
VACCINE (2011)
Conserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responses
Guillermina A. Melendi et al.
VIRUS GENES (2011)
Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years
Peter L. Collins et al.
VIRUS RESEARCH (2011)
Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice
Wenliang Zhang et al.
JOURNAL OF VIROLOGY (2010)
Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naive and Formalin-Inactivated RSV-Immunized BALB/c Mice
Gertrud U. Radu et al.
JOURNAL OF VIROLOGY (2010)
Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein
Yoshihiko Murata et al.
VACCINE (2010)
Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice
Lia M. Haynes et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Respiratory syncytial virus (RSV) vaccines - Two steps back for one leap forward
Ultan F. Power
JOURNAL OF CLINICAL VIROLOGY (2008)
Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives
Raghavendra C. Mundargi et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (RSV) vaccines - Nonadjuvanted vaccine or vaccine adjuvanted with alum - Given concomitantly with influenza vaccine to high-risk elderly individuals
Ann R. Falsey et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Respiratory syncytial virus infection in adults
Ann R. Falsey
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infants
A Marchant et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens
WL Jiang et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Evaluation of BBG2Na in infant macaques:: specific immune responses after vaccination and RSV challenge
L de Waal et al.
VACCINE (2004)
The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B
UF Power et al.
VACCINE (2003)
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women
FM Munoz et al.
VACCINE (2003)
Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate
H Plotnicky et al.
VACCINE (2003)
The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P
RA Tripp et al.
JOURNAL OF VIROLOGY (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Passive transfer of serum antibodies induced by BBG2Na, a subunit vaccine, in the elderly protects SCID mouse lungs against respiratory syncytial virus challenge
H Plotnicky-Gilquin et al.
VIROLOGY (2002)
Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults
UF Power et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines
JE Crowe et al.
JOURNAL OF IMMUNOLOGY (2001)
Identification and characterisation of multiple linear B cell protectopes in the respiratory syncytial virus G protein
UF Power et al.
VACCINE (2001)
Purification of respiratory syncytial virus F and G proteins
C Roder et al.
JOURNAL OF CHROMATOGRAPHY B (2000)
分享论文
